Table of Contents
The Science Behind Vaccines
Carolina Lucas, Ph.D. is a member of the 2018 class of the Pew Latin American Fellows Program. She is a postdoctoral fellow at Yale University, focusing on virology and immunology.
Felicia Goodrum, Ph.D. is a member of the 2008 class of the Pew Biomedical Scholars Program and a 2017 Innovation Fund investigator. She is a researcher and professor at the University of Arizona and BIO5 Institute, focusing on molecular virology and cell biology.
For centuries, vaccines have safeguarded people against infectious disease. Today, roughly 7 out of 10 Americans believe vaccination is important yet recent studies show that vaccination rates in more than half of U.S. states have been on the decline. And with the current push to develop and distribute vaccines in response to COVID-19 the disease caused by the coronavirus SARS-CoV-2 many people have questions about vaccine reliability, safety, and development.
A Berkeley lab s deadly mistake has been fodder for anti-vaxxers for 50 years
sfgate.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sfgate.com Daily Mail and Mail on Sunday newspapers.
A Berkeley lab s deadly mistake has been fodder for anti-vaxxers for 50 years
sfgate.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sfgate.com Daily Mail and Mail on Sunday newspapers.
Five past Coronavirus vaccine drives and how they worked
SECTIONS
Last Updated: Feb 01, 2021, 06:17 AM IST
Share
Synopsis
Scientists developed vaccines less than a year after COVID-19 was identified, a reflection of remarkable progress in vaccine technology. But progress in vaccine distribution is another story.
AP
Some answers can be found in the successes and failures of vaccine drives over the past two centuries.
Scientists developed vaccines less than a year after COVID-19 was identified, a reflection of remarkable progress in vaccine technology. But progress in vaccine distribution is another story.
Questions that arose in vaccine rollouts decades ago are still debated today. How should local and federal authorities coordinate? Who should get vaccinated first? What should officials do about resistance in communities? Should the hardest-hit places be prioritized? Who should pay?
State and local health officials were in charge of the rollout to children, who were most at risk of contracting the disease.
“Young, African-American kids were getting hit, but they were not at the top of the priority list because of the social conditions at the time,” said Dr. René F. Najera, editor of the History of Vaccines project at the College of Physicians of Philadelphia. Noting that it was difficult for parents in working-class jobs to take off time to stand in line with children at clinics, Dr. Najera said, “You see this over and over again, history kind of repeats itself.”